Guizhou Yibai Pharmaceutical Co Ltd (600594) — Capital Reinvestment Ratio
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥33.28 Million) in capital expenditures (CN¥7.08 Million). Check tangible equity quality of Guizhou Yibai Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Yibai Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Guizhou Yibai Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods. For the full cash flow conversion analysis, see Guizhou Yibai Pharmaceutical Co Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. See Guizhou Yibai Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | CN¥256.71 Million | CN¥34.99 Million | ▼ -87.7% |
| 2024 | 1.11x | CN¥86.87 Million | CN¥96.32 Million | ▲ +221.1% |
| 2023 | 0.35x | CN¥377.61 Million | CN¥130.38 Million | ▼ -63.1% |
| 2022 | 0.94x | CN¥345.30 Million | CN¥322.92 Million | ▲ +95.1% |
| 2021 | 0.48x | CN¥934.21 Million | CN¥447.78 Million | ▼ -55.6% |
| 2020 | 1.08x | CN¥366.66 Million | CN¥395.74 Million | ▲ +94.5% |
| 2019 | 0.55x | CN¥362.71 Million | CN¥201.28 Million | ▼ -63.0% |
| 2018 | 1.50x | CN¥214.30 Million | CN¥321.33 Million | ▲ +153.8% |
| 2017 | 0.59x | CN¥681.78 Million | CN¥402.80 Million | ▼ -32.4% |
| 2016 | 0.87x | CN¥380.62 Million | CN¥332.53 Million | ▲ +74.0% |
| 2015 | 0.50x | CN¥573.68 Million | CN¥288.02 Million | ▲ +33.3% |
| 2014 | 0.38x | CN¥541.58 Million | CN¥203.94 Million | ▼ -20.5% |
| 2013 | 0.47x | CN¥577.24 Million | CN¥273.48 Million | ▼ -34.9% |
| 2012 | 0.73x | CN¥288.01 Million | CN¥209.64 Million | ▲ +42.1% |
| 2011 | 0.51x | CN¥277.83 Million | CN¥142.34 Million | ▲ +19.3% |
| 2010 | 0.43x | CN¥115.66 Million | CN¥49.66 Million | ▼ -0.1% |
| 2009 | 0.43x | CN¥103.88 Million | CN¥44.62 Million | ▲ +29.3% |
| 2008 | 0.33x | CN¥189.26 Million | CN¥62.86 Million | ▼ -89.8% |
| 2007 | 3.26x | CN¥11.94 Million | CN¥38.97 Million | ▲ +1738.0% |
| 2006 | 0.18x | CN¥95.77 Million | CN¥17.00 Million | ▼ -96.2% |
| 2005 | 4.66x | CN¥17.38 Million | CN¥80.99 Million | ▲ +153.2% |
| 2003 | 1.84x | CN¥92.10 Million | CN¥169.47 Million | ▲ +501.0% |
| 2002 | 0.31x | CN¥73.46 Million | CN¥22.49 Million | — |